<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Viatris Archives - Insurance Journal</title>
	<atom:link href="https://www.insurancejournal.com/topics/viatris/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.insurancejournal.com/topics/viatris/</link>
	<description>Insurance Journal delivers the latest business news for the Property/Casualty insurance industry</description>
	<lastBuildDate>Fri, 13 Mar 2026 00:15:51 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.2</generator>

<image>
	<url>https://www.insurancejournal.com/app/uploads/2015/12/cropped-insurancejournal-32x32.jpg</url>
	<title>Viatris Archives - Insurance Journal</title>
	<link>https://www.insurancejournal.com/topics/viatris/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Viatris Settles Lawsuit Over Use of Maryland Woman&#8217;s Cells in Drug Research</title>
		<link>https://www.insurancejournal.com/news/east/2026/03/13/861790.htm</link>
		
					<dc:creator><![CDATA[Admin]]></dc:creator>
					<pubDate>Fri, 13 Mar 2026 05:00:25 +0000</pubDate>
				<category><![CDATA[East News]]></category>
		<category><![CDATA[drug manufacturer liability]]></category>
		<category><![CDATA[drug research]]></category>
		<category><![CDATA[Henrietta Lacks]]></category>
		<category><![CDATA[Viatris]]></category>
		<guid isPermaLink="false">https://www.insurancejournal.com/?p=861790</guid>

							<description><![CDATA[Generic drugmaker Viatris has settled a lawsuit brought by the family of Henrietta Lacks, a Maryland woman whose tissue samples were used without her permission to develop enduring cells for lucrative medical research. Viatris and Lacks&#8217; estate told a federal &#8230;]]></description>
		
		
		
			</item>
		<item>
		<title>Viatris to Pay Up to $335 Million to Resolve Opioid-Related Claims</title>
		<link>https://www.insurancejournal.com/news/national/2025/04/07/818839.htm</link>
		
				<pubDate>Mon, 07 Apr 2025 14:23:05 +0000</pubDate>
				<category><![CDATA[National News]]></category>
		<category><![CDATA[Mylan Inc.]]></category>
		<category><![CDATA[opioid settlements]]></category>
		<category><![CDATA[opioids]]></category>
		<category><![CDATA[Viatris]]></category>
		<guid isPermaLink="false">https://www.insurancejournal.com/?p=818839</guid>

							<description><![CDATA[Viatris said on Monday it would pay up to $335 million over nine years as part of a nationwide settlement to resolve opioid-related claims against the drugmaker. Shares of the Pennsylvania-based company, formed by the merger of Mylan and Pfizer&#8217;s &#8230;]]></description>
		
		
		
		<enclosure url="https://www.insurancejournal.com/app/uploads/2017/10/database-in-nevada-aims-to-accurately-depict-580x387.jpg" length="28280" type="image/jpeg" />	</item>
	</channel>
</rss>
